Zepp Health (NYSE:ZEPP) Downgraded to Sell Rating by Wall Street Zen

Zepp Health (NYSE:ZEPPGet Free Report) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report released on Sunday.

Separately, Fundamental Research set a $56.28 price target on Zepp Health and gave the stock a “buy” rating in a research report on Wednesday, April 22nd. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Zepp Health currently has an average rating of “Hold” and a consensus target price of $56.28.

Check Out Our Latest Analysis on ZEPP

Zepp Health Stock Performance

Zepp Health stock opened at $4.93 on Friday. The company’s 50-day moving average price is $6.00 and its 200-day moving average price is $14.00. The company has a quick ratio of 0.67, a current ratio of 0.88 and a debt-to-equity ratio of 0.21. The company has a market cap of $72.45 million, a PE ratio of -1.96 and a beta of 1.83. Zepp Health has a twelve month low of $3.85 and a twelve month high of $61.85.

Insider Buying and Selling

In other Zepp Health news, CFO Cheng Deng sold 9,836 shares of the business’s stock in a transaction on Friday, June 26th. The shares were sold at an average price of $4.61, for a total transaction of $45,343.96. Following the transaction, the chief financial officer owned 114,539 shares in the company, valued at $528,024.79. The trade was a 7.91% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 36.00% of the stock is owned by insiders.

Institutional Investors Weigh In On Zepp Health

Institutional investors have recently made changes to their positions in the company. Public Employees Retirement System of Ohio increased its position in shares of Zepp Health by 61.4% during the fourth quarter. Public Employees Retirement System of Ohio now owns 1,514 shares of the company’s stock worth $41,000 after acquiring an additional 576 shares during the period. Harvest Fund Management Co. Ltd raised its stake in shares of Zepp Health by 6.7% during the fourth quarter. Harvest Fund Management Co. Ltd now owns 44,800 shares of the company’s stock valued at $1,207,000 after acquiring an additional 2,800 shares in the last quarter. Osaic Holdings Inc. boosted its holdings in shares of Zepp Health by 239.5% in the fourth quarter. Osaic Holdings Inc. now owns 8,285 shares of the company’s stock valued at $223,000 after purchasing an additional 5,845 shares during the period. Dimensional Fund Advisors LP purchased a new stake in shares of Zepp Health in the fourth quarter valued at approximately $241,000. Finally, Capstone Capital Management Ltd bought a new position in Zepp Health in the fourth quarter worth approximately $298,000. Institutional investors own 52.61% of the company’s stock.

About Zepp Health

(Get Free Report)

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.

Read More

Receive News & Ratings for Zepp Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zepp Health and related companies with MarketBeat.com's FREE daily email newsletter.